Nijmegen, the Netherlands – Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, is thrilled to announce the integration of its NephroPath AI tools into HistoWiz’s PathologyMap™ platform....

Nijmegen, the Netherlands –  Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has announced that its algorithm for mitotic figure counting has achieved CE marking under the In Vitro Diagnostic...

Key takeaways Avoiding workflow bottlenecks: Processing ~1,200 slides daily, Radboudumc faces the challenge of maintaining high-quality WSIs without disrupting efficiency. A comprehensive manual artifact inspection would require...

Aiosyn: The impact of diabetes on kidney health: understanding diabetic nephropathy Diabetes is a chronic condition that significantly impacts kidney health, often leading to a serious complication known as diabetic nephropathy. Over...

Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has introduced its external digital slide quality assessments to support laboratories in achieving good-quality histology slides—essential for...

Aiosyn announces webinar for next month November 5 4:00 PM CET | 10:00 AM ET | 7:00 AM PT REGISTER NOW Join us for our 45-minute webinar where we explore the challenges of manual quality control (QC) in digital pathology and how...